DURHAM, NC--(Marketwire - November 19, 2007) - Aldagen, Inc., a biotechnology company advancing a pipeline of clinical-stage regenerative therapies, today announced that W. Thomas Amick, Chairman and CEO of Aldagen, will be presenting at the 19th Annual Piper Jaffray Health Care Conference taking place from November 27-29 in New York, NY. During the presentation, Mr. Amick will provide an overview of the company including recent clinical and strategic developments.
